Transforming growth factor-beta 1 and glial growth factor 2 reduce neurotrophin-3 mRNA expression in cultured Schwann cells via a cAMP-dependent pathway

The aim of the study was to determine which factors regulated the expressio n of neurotrophin-3 (NT-3) mRNA in cultured primary Schwann cells derived f rom sciatic nerve of neonatal rats. Treatment of primary Schwann cells with the adenylate cyclase activator, forskolin, or the cAMP agonist, 8-Br-cAMP , induced a significant reduction in NT-3 transcript levels. Transforming g rowth factor-beta 1 (TGF-beta 1) and glial growth factor 2 (GGF(2)) also re duced the levels of NT-3 mRNA in a dose and time-dependent manner. Treatmen t with nerve growth factor, brain-derived neurotrophic factor, NT-3, ciliar y neurotrophic factor or interleukin-1 beta was without effect. The TGF-bet a 1, GGF(2) and forskolin dependent reduction in NT-3 mRNA levels involved a destabilization of transcripts which was antagonised by co-treatment with cycloheximide. The cAMP-dependent protein kinase A (PKA) inhibitor, H-89, blocked the reduction in levels of NT-3 mRNA induced by TGF-beta 1, GGF(2) and forskolin. The data show that the effects of TGF-beta 1, GGF(2) and for skolin on the downregulation of NT-3 mRNA, at least in part, were due to a post-transcriptional event involving a labile protein intermediate under th e control of PKA. The results suggest that the down-regulation of NT-3 mRNA in Schwann cells at a site of peripheral nerve damage may be mediated via a cAMP-dependent pathway and possibly involve neuroma-related elevations in TGF-beta 1 and GGF(2). (C) 1999 Published by Elsevier Science B.V. All rig hts reserved.